MACKENZIE FINANCIAL CORP
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 919859
TORONTO ONTARIO, A6
Position in IRWD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,967,145
+$8,001,426 QoQ
Shares Held
2,367,493
+322.7% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 212 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. IRWD ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
This page
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in IRWD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,967,145 | 2,367,493 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,965,719 | 560,034 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $38,903 | 11,544 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $13,702 | 10,460 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,531 | 10,460 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,376 | 10,460 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $46,337 | 10,460 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $43,095 | 10,460 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $68,199 | 10,460 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $91,106 | 10,460 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $119,662 | 10,460 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $122,426 | 12,713 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $111,294 | 10,460 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $110,039 | 10,460 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $129,599 | 10,460 | Shares | Sole | 2023-02-14 | |
| 2020-12-31 | $519,634 | 45,622 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $847,900 | 94,316 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $750,945 | 72,766 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $737,679 | 73,110 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||